Intrinsiqs

Is Maze Therapeutics, Inc. overvalued?

Maze Therapeutics, Inc. (MAZE) — key valuation metrics and fundamentals.

No verdict
Price
$27.11
Fair value
Current P/E
Normal P/E
Market cap
$1.50B
Dividend yield
0.0%
Return on equity
-36.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MAZE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.